These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 36044595)

  • 1. A targetable pathway in neutrophils mitigates both arterial and venous thrombosis.
    Nayak L; Sweet DR; Thomas A; Lapping SD; Kalikasingh K; Madera A; Vinayachandran V; Padmanabhan R; Vasudevan NT; Myers JT; Huang AY; Schmaier A; Mackman N; Liao X; Maiseyeu A; Jain MK
    Sci Transl Med; 2022 Aug; 14(660):eabj7465. PubMed ID: 36044595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated signature of antiphospholipid syndrome neutrophils reveals potential therapeutic target.
    Knight JS; Meng H; Coit P; Yalavarthi S; Sule G; Gandhi AA; Grenn RC; Mazza LF; Ali RA; Renauer P; Wren JD; Bockenstedt PL; Wang H; Eitzman DT; Sawalha AH
    JCI Insight; 2017 Sep; 2(18):. PubMed ID: 28931754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface Geometry of Cargo-less Gold Nanoparticles Is a Driving Force for Selective Targeting of Activated Neutrophils to Reduce Thrombosis in Antiphospholipid Syndrome.
    Di L; Thomas A; Switala L; Kalikasingh K; Lapping S; Nayak L; Maiseyeu A
    Nano Lett; 2023 Nov; 23(21):9690-9696. PubMed ID: 37884274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Release of neutrophil extracellular traps by neutrophils stimulated with antiphospholipid antibodies: a newly identified mechanism of thrombosis in the antiphospholipid syndrome.
    Yalavarthi S; Gould TJ; Rao AN; Mazza LF; Morris AE; Núñez-Álvarez C; Hernández-Ramírez D; Bockenstedt PL; Liaw PC; Cabral AR; Knight JS
    Arthritis Rheumatol; 2015 Nov; 67(11):2990-3003. PubMed ID: 26097119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defibrotide Inhibits Antiphospholipid Antibody-Mediated Neutrophil Extracellular Trap Formation and Venous Thrombosis.
    Ali RA; Estes SK; Gandhi AA; Yalavarthi S; Hoy CK; Shi H; Zuo Y; Erkan D; Knight JS
    Arthritis Rheumatol; 2022 May; 74(5):902-907. PubMed ID: 34725956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vivo Role of Neutrophil Extracellular Traps in Antiphospholipid Antibody-Mediated Venous Thrombosis.
    Meng H; Yalavarthi S; Kanthi Y; Mazza LF; Elfline MA; Luke CE; Pinsky DJ; Henke PK; Knight JS
    Arthritis Rheumatol; 2017 Mar; 69(3):655-667. PubMed ID: 27696751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Adhesive Potential of Antiphospholipid Syndrome Neutrophils Mediated by β2 Integrin Mac-1.
    Sule G; Kelley WJ; Gockman K; Yalavarthi S; Vreede AP; Banka AL; Bockenstedt PL; Eniola-Adefeso O; Knight JS
    Arthritis Rheumatol; 2020 Jan; 72(1):114-124. PubMed ID: 31353826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of antiphospholipid antibody syndrome: a systematic review.
    Lim W; Crowther MA; Eikelboom JW
    JAMA; 2006 Mar; 295(9):1050-7. PubMed ID: 16507806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiphospholipid antibody-mediated effects in an arterial model of thrombosis are dependent on Toll-like receptor 4.
    Laplante P; Fuentes R; Salem D; Subang R; Gillis MA; Hachem A; Farhat N; Qureshi ST; Fletcher CA; Roubey RA; Merhi Y; Thorin É; Levine JS; Mackman N; Rauch J
    Lupus; 2016 Feb; 25(2):162-76. PubMed ID: 26391610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting thromboinflammation in antiphospholipid syndrome.
    Salet DM; Bekkering S; Middeldorp S; van den Hoogen LL
    J Thromb Haemost; 2023 Apr; 21(4):744-757. PubMed ID: 36696191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of Recurrent Thrombosis in Antiphospholipid Syndrome: Different from the General Population?
    Legault KJ; Ugarte A; Crowther MA; Ruiz-Irastorza G
    Curr Rheumatol Rep; 2016 May; 18(5):26. PubMed ID: 27032789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
    Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
    J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arterial and venous thrombosis is associated with different angiogenic cytokine patterns in patients with antiphospholipid syndrome.
    Smadja D; Gaussem P; Roncal C; Fischer AM; Emmerich J; Darnige L
    Lupus; 2010 Jun; 19(7):837-43. PubMed ID: 20133349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Following 90 patients with antiphospholipid syndrome with antibody titers and correlations with clinical manifestations: symptoms of the disease, a new antibody and correlations with clinical manifestations in the Israeli population].
    Marai I; Levi Y; Godard G; Shoenfeld Y
    Harefuah; 2001 Jun; 140(6):495-500, 565. PubMed ID: 11420848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiplatelet and anticoagulant agents for primary prevention of thrombosis in individuals with antiphospholipid antibodies.
    Bala MM; Paszek E; Lesniak W; Wloch-Kopec D; Jasinska K; Undas A
    Cochrane Database Syst Rev; 2018 Jul; 7(7):CD012534. PubMed ID: 30004572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The clinical manifestations and thrombotic risk factors in primary antiphospholipid syndrome].
    Zhao JL; Sun YD; Zhang Y; Xu D; Wang Q; Li MT; Zeng XF
    Zhonghua Nei Ke Za Zhi; 2016 May; 55(5):386-91. PubMed ID: 27143190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antiphospholipid syndrome: still an enigma.
    Chaturvedi S; McCrae KR
    Hematology Am Soc Hematol Educ Program; 2015; 2015():53-60. PubMed ID: 26637701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additional risk factors associated with thrombosis and pregnancy morbidity in a unique cohort of antiphospholipid antibody-positive patients.
    Li C; Zuo Y; Zhang S; Makris UE; Karp DR; Li Z
    Chin Med J (Engl); 2022 Mar; 135(6):658-664. PubMed ID: 35143425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arterial thrombosis in antiphospholipid syndrome (APS): Clinical approach and treatment. A systematic review.
    Cheng C; Cheng GY; Denas G; Pengo V
    Blood Rev; 2021 Jul; 48():100788. PubMed ID: 33341301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Biomarkers for Atherothrombosis in Antiphospholipid Syndrome: Genomics and Epigenetics Approaches.
    Lopez-Pedrera C; Barbarroja N; Patiño-Trives AM; Collantes E; Aguirre MA; Perez-Sanchez C
    Front Immunol; 2019; 10():764. PubMed ID: 31040845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.